Zeidan, A. M., Platzbecker, U., Garcia-Manero, G., Sekeres, M. A., Fenaux, P., DeZern, A. E., Greenberg, P. L., Savona, M. R., Jurcic, J. G., Verma, A. K., Mufti, G. J., Buckstein, R., Santini, V., Shetty, J. K., Ito, R., Zhang, J., Zhang, G., Ha, X., Backstrom, J. T., & Komrokji, R. S. (2022). Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood, 140(20), 2170–2174. https://doi.org/10.1182/blood.2022016171
Subjects:
Activin Receptors, Type II
(MeSH)
Myelodysplastic Syndromes
(MeSH)
Acute Myeloid Leukemia
(OpenAlex Topic)
Molecular Pathogenesis of Myeloproliferative Disorders
(OpenAlex Topic)
Vascular Tumors and Angiosarcoma
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood.2022016171
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: